Fortress - FBIO Net earnings per one share for the last twelve months

Fortress Biotech Corp (FBIO) - corporate logo

Fortress Biotech, Inc. (FBIO) manages its assets using specialized software, although patent expertise remains with human specialists. The company's revenues are limited by insurance terms and licensing payments, with the current figure standing at 1609.20. The business relies on an incubator model, transforming scientific ideas into marketable drugs. This price chart clearly demonstrates the earnings per share (EPS) dynamics for Fortress Biotech, Inc. (FBIO).

Fortress Biotech, Inc. (FBIO): Net earnings per share for the last 12 months from 02/11/2024 to 11/17/2026

Financial and market metric breakdowns for Fortress Biotech, Inc. (FBIO)

- share price and consensus valuation forecast:
Initial company analysis:FBIO, Fortress Biotech Inc
Original product of Fortress Biotech Corp

The Fortress Biotech, Inc. (FBIO) model, based on the creation of subsidiary startups and the recruitment of M&A experts, directly impacts the efficiency of asset capitalization. Current EPS YoY TTM dynamics reflect the annual change in earnings per share over a rolling period, allowing for a comparison between the company's market value and its actual ability to generate net income to identify fundamental undervaluation or business overheating.